文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

针对癌症中的铁死亡脆弱性。

Targeting ferroptosis as a vulnerability in cancer.

机构信息

Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

The University of Texas MD Anderson UTHealth Graduate School of Biomedical Sciences, Houston, TX, USA.

出版信息

Nat Rev Cancer. 2022 Jul;22(7):381-396. doi: 10.1038/s41568-022-00459-0. Epub 2022 Mar 25.


DOI:10.1038/s41568-022-00459-0
PMID:35338310
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10243716/
Abstract

Ferroptosis is an iron-dependent form of regulated cell death that is triggered by the toxic build-up of lipid peroxides on cellular membranes. In recent years, ferroptosis has garnered enormous interest in cancer research communities, partly because it is a unique cell death modality that is mechanistically and morphologically different from other forms of cell death, such as apoptosis, and therefore holds great potential for cancer therapy. In this Review, we summarize the current understanding of ferroptosis-inducing and ferroptosis defence mechanisms, dissect the roles and mechanisms of ferroptosis in tumour suppression and tumour immunity, conceptualize the diverse vulnerabilities of cancer cells to ferroptosis, and explore therapeutic strategies for targeting ferroptosis in cancer.

摘要

铁死亡是一种依赖于铁的细胞程序性死亡形式,由细胞膜上脂质过氧化物的毒性积累引发。近年来,铁死亡在癌症研究领域引起了极大的关注,部分原因是它是一种独特的细胞死亡方式,在机制和形态上不同于其他形式的细胞死亡,如细胞凋亡,因此在癌症治疗方面具有巨大的潜力。在这篇综述中,我们总结了目前对铁死亡诱导和铁死亡防御机制的理解,剖析了铁死亡在肿瘤抑制和肿瘤免疫中的作用和机制,阐述了癌细胞对铁死亡的不同脆弱性,并探讨了针对癌症中铁死亡的治疗策略。

相似文献

[1]
Targeting ferroptosis as a vulnerability in cancer.

Nat Rev Cancer. 2022-7

[2]
The roles of ferroptosis in cancer: Tumor suppression, tumor microenvironment, and therapeutic interventions.

Cancer Cell. 2024-4-8

[3]
Ferroptosis: a novel regulated cell death participating in cellular stress response, radiotherapy, and immunotherapy.

Exp Hematol Oncol. 2023-7-27

[4]
The putative role of ferroptosis in gastric cancer: a review.

Eur J Cancer Prev. 2023-11-1

[5]
A guide to ferroptosis in cancer.

Mol Oncol. 2024-6

[6]
Pharmacological Targeting of Ferroptosis in Cancer Treatment.

Curr Cancer Drug Targets. 2022

[7]
Insight into Iron, Oxidative Stress and Ferroptosis: Therapy Targets for Approaching Anticancer Strategies.

Cancers (Basel). 2024-3-20

[8]
Ferroptosis as a New Type of Cell Death and its Role in Cancer Treatment.

Klin Onkol. 2018

[9]
Ferroptosis at the crossroads of tumor-host interactions, metastasis, and therapy response.

Am J Physiol Cell Physiol. 2022-7-1

[10]
A comprehensive overview of recent developments on the mechanisms and pathways of ferroptosis in cancer: the potential implications for therapeutic strategies in ovarian cancer.

Cancer Drug Resist. 2023-8-11

引用本文的文献

[1]
Recent Advancement in MRI-Based Nanotheranostic Agents for Tumor Diagnosis and Therapy Integration.

Int J Nanomedicine. 2025-8-29

[2]
Targeting ALDH16A1 mediated thioredoxin lysosomal degradation to enhance ferroptosis susceptibility in SMARCA4-deficient NSCLC.

Nat Commun. 2025-9-2

[3]
Synergistic Ferroptosis-Immunotherapy Nanoplatforms: Multidimensional Engineering for Tumor Microenvironment Remodeling and Therapeutic Optimization.

Nanomicro Lett. 2025-9-2

[4]
The transcriptional regulation of NUPR1 expression by MYC is implicated in the regulation of ferroptosis in human spermatogonial stem cells.

Cell Mol Life Sci. 2025-9-2

[5]
Cooperative targeting of NF-κB enhances ferroptosis-driven HCC therapy with Alisertib and Donafenib.

Front Cell Dev Biol. 2025-8-13

[6]
FoxO3a: capture the bond between magnesium and diabetic kidney disease.

Front Endocrinol (Lausanne). 2025-8-13

[7]
Ferroptosis as a Form of Cell Death-Medical Importance and Pharmacological Implications.

Pharmaceuticals (Basel). 2025-8-11

[8]
Ferroptosis and Nrf2 Signaling in Head and Neck Cancer: Resistance Mechanisms and Therapeutic Prospects.

Antioxidants (Basel). 2025-8-13

[9]
Carnitine Shuttle and Ferroptosis in Cancer.

Antioxidants (Basel). 2025-8-8

[10]
Roles and Prospective Applications of Ferroptosis Suppressor Protein 1 (FSP1) in Malignant Tumor Treatment.

Curr Oncol. 2025-8-14

本文引用的文献

[1]
PKCβII phosphorylates ACSL4 to amplify lipid peroxidation to induce ferroptosis.

Nat Cell Biol. 2022-1

[2]
Dysregulated cholesterol homeostasis results in resistance to ferroptosis increasing tumorigenicity and metastasis in cancer.

Nat Commun. 2021-8-24

[3]
Selenium-GPX4 axis protects follicular helper T cells from ferroptosis.

Nat Immunol. 2021-9

[4]
GOT1 inhibition promotes pancreatic cancer cell death by ferroptosis.

Nat Commun. 2021-8-11

[5]
Mitochondrial regulation of ferroptosis.

J Cell Biol. 2021-9-6

[6]
Sorafenib fails to trigger ferroptosis across a wide range of cancer cell lines.

Cell Death Dis. 2021-7-13

[7]
Ether phospholipids govern ferroptosis.

J Genet Genomics. 2021-7-20

[8]
The glutathione peroxidase Gpx4 prevents lipid peroxidation and ferroptosis to sustain Treg cell activation and suppression of antitumor immunity.

Cell Rep. 2021-6-15

[9]
iPLA2β-mediated lipid detoxification controls p53-driven ferroptosis independent of GPX4.

Nat Commun. 2021-6-15

[10]
mTORC1 and ferroptosis: Regulatory mechanisms and therapeutic potential.

Bioessays. 2021-8

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索